Lv57
1154 积分 2022-08-12 加入
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors
2天前
已完结
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors
2天前
已完结
PD-1 or PD-L1—A Difference That Makes No Difference?
3天前
已完结
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer
3天前
已完结
PCSK9-directed therapies: an update
4天前
已完结
New Oral PCSK9 Inhibitor: “MK-0616”
4天前
已完结
Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design
4天前
已完结
Total Synthesis of Enlicitide Decanoate
4天前
已完结
Design, Synthesis, and Characterization of GluN2A Negative Allosteric Modulators Suitable for In Vivo Exploration
4天前
已完结
Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma
9天前
已完结
皖公网安备34019202002308
